Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets.
Jason L Liggett, Xiaobo Zhang, Thomas E Eling, Seung Joon Baek
Index: Cancer Lett. 346(2) , 217-24, (2014)
Full Text: HTML
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are used extensively for analgesic and antipyretic treatments. In addition, NSAIDs reduce the risk and mortality to several cancers. Their mechanisms in anti-tumorigenesis are not fully understood, but both cyclooxygenase (COX)-dependent and -independent pathways play a role. We and others have been interested in elucidating molecular targets of NSAID-induced apoptosis. In this review, we summarize updated literature regarding cellular and molecular targets modulated by NSAIDs. Among those NSAIDs, sulindac sulfide and tolfenamic acid are emphasized in this review because these two drugs have been well investigated for their anti-tumorigenic activity in many different types of cancer. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Related Compounds
Related Articles:
Pharmacological protection of retinal pigmented epithelial cells by sulindac involves PPAR-α.
2014-11-25
[Proc. Natl. Acad. Sci. U. S. A. 111(47) , 16754-9, (2014)]
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2011-12-01
[J. Sci. Ind. Res. 65(10) , 808, (2006)]
The Japanese toxicogenomics project: application of toxicogenomics.
2010-02-01
[Mol. Nutr. Food. Res. 54 , 218-27, (2010)]
Developing structure-activity relationships for the prediction of hepatotoxicity.
2010-07-19
[Chem. Res. Toxicol. 23 , 1215-22, (2010)]